This Collection welcomes original research examining immune evasion in cancer, including studies examining mechanisms of immune evasion and immunotherapies targeting immune evasion.

▎药明康德内容团队编辑  乳酸是一种糖酵解代谢产物，在过去的一段时间里，它被看作是一种无氧呼吸产生的代谢废物。然而，近些年的研究表明，乳酸可以在细胞分子水平发挥多种作用，它既能充当糖异生的主要前体，也可以作为分子信号，参与基因转录、线粒体呼吸等各种细 ...

known as Tumor-Associated Collagen Signatures (TACS), in cancer progression and immune evasion. TACS1 and TACS2 patterns create "immune deserts" around tumors, limiting immune cell movement and ...

Dendritic cells are poised to revolutionize oncology. This type of immune therapy shows effectiveness even in late-stage ...

Research reveals SLC13A3's role in tumor cell survival and immune therapy resistance, highlighting its potential as a target ...

A team from Nanjing Leads Biolabs Co. Ltd. presented the discovery and preclinical characterization of LBL-042, a novel bispecific antibody designed to simultaneously target PD-1 and LILRB1/2, with ...

During the three months ended September 30, 2024, the Company sold, under the Open Market Sale Agreement with Jefferies LLC, ...

A ground breaking study mapping the immune microenvironment in Multiple Myeloma identifies critical immune changes and ...

(“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic intended to improve the outcomes and quality of life for patients, ...